Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies

AIDS Research and Human Retroviruses

Volumn 18, Issue 16, 2002, Pages 1207-1217

  Xiang, Shi Hua ^a,b   Doka, Najah ^a   Choudhary, Rabeéa K ^a   Sodroski, Joseph ^a,b,c   Robinson, James E ^d  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; EPITOPE; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 17B; MONOCLONAL ANTIBODY 21C; MONOCLONAL ANTIBODY 23E; MONOCLONAL ANTIBODY 48D; MONOCLONAL ANTIBODY 49E; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BINDING ASSAY; BINDING SITE; CASE REPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; RECEPTOR BINDING; SERODIAGNOSIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; NEUTRALIZATION TESTS; PROTEIN CONFORMATION;

EID: 0036436313     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260387959     Document Type: Article

References (51)

1. Barre-Sinossi F, Chermann F, Rey MT, et al.: Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983;220:868-871.
2. Gallo RC, Salahuddin SZ, Popovic M, et al.: Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984;224:500-503.
3. Cicala C, Arthos J, Rubbert A, et al.: HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. Proc Natl Acad Sci USA 2000;97(3):1178-1183.
4. Fauci AS: The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988;239(4840):617-622.
5. Fauci AS: Immunopathogenesis of HIV infection. J Acquir Immune Defic Syndr 1993;6(6):655-662.
6. Gougeon ML, Garcia S, Heeney J, et al.: Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 1993;9(6):553-563.
7. Gougeon ML, Montagnier L: Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann NY Acad Sci 1999;887:199-212.
8. Rosenberg ZF and Fauci AS: Immunopathogenetic mechanisms of HIV infection. Clin Immunol Immunopathol 1989;50(1 Pt. 2):S149-156.
9. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, and Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312(5996):763-767.
10. Deng H, Liu R, Ellmeier W, et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381(6584):661-666.
11. Klatzmann D, Champagne E, Chamaret S, et al.: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-768.
12. Mirzabekov T, Bannert N, Farzan M, et al.: Enhanced expression, native purification, and characterization of CCR5, a principal HIV1 coreceptor. J Biol Chem 1999;274(40):28745-28750.
13. Blacklow SC, Lu M, and Kim PS: A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 1995;34(46):14955-14962.
14. Bleul CC, Farzan M, Choe H, et al.: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382(6594):829-833.
15. Choe H, Farzan M, Sun Y, et al.: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85(7):1135-1148.
16. Choe H, Martin KA, Farzan M, Sodroski J, Gerard NP, and Gerard C. Structural interactions between chemokine receptors, gpl20 Env and CD4. Semin Immunol 1998;10(3):249-257.
17. Deichmann M, Kronenwett R, and Haas R: Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD4+ hematopoietic progenitor cells. Blood 1997;89(10):3522-3528.
18. Delezay O, Koch N, Yahi N, et al.: Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS 1997;11(11):1311-1318.
19. Sodroski J, Wyatt R, Olshevsky U, Olshevsky V, and Moore J. Conformation of the HIV-1 gp120 envelope glycoprotein. Antibiot Chemother 1996;48:184-187.
20. Sullivan N, Sun Y, Sattentau Q, et al.: CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization. J Virol 1998;72(6):4694-4703.
21. Wyatt R, Kwong PD, Desjardins E, et al.: The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 1998;393(6686):705-711.
22. Wyatt R, Moore J, Accola M, Desjardin E, Robinson J, and Sodroski J. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. J Virol 1995;69(9):5723-5733.
23. Rizzuto C and Sodroski J. Fine definition of a conserved CCR5binding region on the human immunodeficiency virus type 1 glycoprotein 120. AIDS Res Hum Retroviruses 2000; 16(8):741-749.
24. Rizzuto CD, Wyatt R, Hernandez-Ramos N, et al.: A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science 1998;280(5371):1949-1953.
25. Thali M, Furman C, Wahren B, et al.: Cooperativity of neutralizing antibodies directed against the V3 and CD4 binding regions of the human immunodeficiency virus gpl20 envelope glycoprotein. J Acquir Immune Defic Syndr 1992;5(6):591-599.
26. Ye Y, Si ZH, Moore JP, and Sodroski J: Association of structural changes in the V2 and V3 loops of the gp120 envelope glycoprotein with acquisition of neutralization resistance in a simian-human immunodeficiency virus passaged in vivo. J Virol 2000;74(24):11955-11962.
27. Zhang W, Canziani G, Plugariu C, et al.: Conformational changes of gpl20 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry 1999;38(29):9405-9416.
28. Kwong PD, Wyatt R, Majeed S, et al.: Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Struct Fold Des 2000;8(12):1329-1339.
29. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, and Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393(6686):648-659.
30. Moore JP and Sodroski J: Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein. J Virol 1996;70(3):1863-1872.
31. Chan DC, Fass D, Berger JM, and Kim PS: Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89(2):263-273.
32. Kim EM, Lee KH, and Kim JW: The cytoplasmic domain of HIV1 gp41 interacts with the carboxyl-terminal region of alpha-catenin. Mol Cells 1999;9(3):281-285.
33. Finzi D and Siliciano RF: Viral dynamics in HIV-1 infection. Cell 1998;93(5):665-671.
34. Siliciano JD and Siliciano RF: Latency and viral persistence in HIV-1 infection. J Clin Invest 2000;106(7):823-825.
35. Wyatt R and Sodroski J: The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science 1998;280(5371):1884-1888.
36. Binley JM, Wyatt R, Desjardins E, et al.: Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. AIDS Res Hum Retroviruses 1998;14(3):191-198.
37. Thali M, Charles M, Furman C, et al.: Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change. J Virol 1994;68(2):674-680.
38. Thali M, Moore JP, Furman C, et al.: Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993;67(7):3978-3988.
39. Cao J, Sullivan N, Desjardin E, et al.: Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol 1997;71(12):9808-9812.
40. Sullivan N, Sun Y, Binley J, et al.: Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies. J Virol 1998;72(8):6332-6338.
41. Sullivan N, Thali M, Furman C, Ho DD, and Sodroski J: Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J Virol 1993;67(6):3674-3679.
42. Thali M, Olshevsky U, Furman C, Gabuzda D, Li J, and Sodroski J: Effects of changes in gpl20-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol 1991;65(9):5007-5012.
43. Thali M, Olshevsky U, Furman C, Gabuzda D, Posner M, and Sodroski J: Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J Virol 1991;65(11):6188-6193.
44. Wu L, Gerard NP, Wyatt R, et al.: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996;384(6605): 179-183.
45. Korber B, Foley F, Kuiken C, Pillai S, and Sodroski J: Numbering positions in HIV relative to HXBc2. In: B. Korber, C. Kuiken, B. Foley, B. Hahn, F. McCutchen, J. Mellors, and J. Sodroski (eds.) Human Retroviruses and AIDS 1998. Los Alamos, NM: Los Alamos Laboratory, 1998.
46. Robinson JE, Cole KS, Elliott DH, et al.: Production and characterization of SIV envelope-specific rhesus monoclonal antibodies from a macaque asymptomatically infected with a live SIV vaccine. AIDS Res Hum Retroviruses 1998;14(14):1253-1262.
47. Robinson JE, Holton D, Liu J, McMurdo H, Murciano A, and Gohd R: A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter wells coated with concanavalin. J Immunol Methods 1990;132:63-71.
48. Dragic T, Trkola A, Lin SW, et al.: Amino-terminal substitutions in the CCR5 coreceptor impair gpl20 binding and human immunodeficiency virus type 1 entry. J Virol 1998;72(1):279-285.
49. Farzan M, Vasilieva N, Schnitzler CE, et al.: A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4enhanced epitope of the HIV-1 gpl20 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem 2000;275(43):33516-21.
50. Myszka DG, Sweet RW, Hensley P, et al.: Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci USA 2000; 97(16):9026-9031.
51. Kolchinsky P, Kiprilov E, Bartley P, Rubinstein R, and Sodroski J: Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops. J Virol 2001;75(7):3435-3443.